logo
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • The Problem
    • The Solution
    • Benefits
  • Pipeline
    • Regulatory Pathway
    • Initial Focus
  • Partnering
    • Core Values
    • Partnering Philosophy
    • Partnering Focus
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • Governance
    • Financials
    • Investor Resources
  • Contact

Category: Press Release


30th May 2019

TFF Pharmaceuticals Raises $8.17 Million and Expands Leadership Team with New CFO and Director Appointments

27th September 2018

TFF Pharmaceuticals Receives Notice of Intention to Grant European Patent for Its Thin Film Freezing Process, Providing IP Protection in Europe until 2028

11th July 2018

TFF Pharmaceuticals Receives Notice of Allowance for New Foundational Patent Broadly Covering Novel Inhaled Dry Powder Drug Delivery Platform

8th May 2018

TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer

3rd May 2018

Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform

Recent Posts

  • TFF Pharmaceuticals Raises $8.17 Million and Expands Leadership Team with New CFO and Director Appointments
  • TFF Pharmaceuticals Receives Notice of Intention to Grant European Patent for Its Thin Film Freezing Process, Providing IP Protection in Europe until 2028
  • TFF Pharmaceuticals Receives Notice of Allowance for New Foundational Patent Broadly Covering Novel Inhaled Dry Powder Drug Delivery Platform
  • TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
  • Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform

Recent Comments

    Archives

    • May 2019
    • September 2018
    • July 2018
    • May 2018

    Categories

    • Press Release

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About

    Management Board of Directors Fact Sheet

    Science

    The Problem The Solution Benefits

    Pipeline

    Regulatory Pathway Initial Focus

    More

    Investors Contact

    © 2022 TFF PHARMACEUTICALS, INC.

    All Rights Reserved.

    Accessibility Statement    Privacy Policy
    Top